AKT1 and neoplasm: Of particular note AKT phosphorylation at S473 and T308 were increased following dosing of tumour xenografts in vivo and in two different cell line models in vitro indicating these may represent stable molecular biomarkers of AKT inhibition by a catalytic domain inhibitor.